Back
Lemonade Vs. Viking Therapeutics Industry Stock Comparison
Buy
66
LMND
Lemonade
Last Price:
16.50
Seasonality Move:
-19.54%
Sell
44
VKTX
Viking Therapeutics
Last Price:
52.96
Seasonality Move:
1.76%
Buy
66
Lemonade (LMND)
is a Buy
Is Lemonade a Buy, Sell or Hold?
- The current Lemonade [LMND] share price is $16.46. The Score for LMND is 66, which is 32% above its historic median score of 50, and infers lower risk than normal.
- LMND is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Sell
44
Viking Therapeutics (VKTX)
is a Sell
Is Viking Therapeutics a Buy, Sell or Hold?
- The current Viking Therapeutics [VKTX] share price is $50.77. The Score for VKTX is 44, which is 12% below its historic median score of 50, and infers higher risk than normal.
- VKTX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
LMND Stock Price Chart
VKTX Stock Price Chart
What is Viking Therapeutics's stock price today?
-
The Viking Therapeutics share price today is $50.77
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VKTX is experiencing buying pressure, which is a positive indicator for future bullish movement.
LMND Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.14 | Sell |
| Relative Strength Index (14 RSI): | 52.43 | Buy |
| Chaikin Money Flow: | -82386 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (15.57 - 16.61) | Buy |
| Bollinger Bands (100): | (15.75 - 17.75) | Sell |
VKTX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -4.32 | Sell |
| Relative Strength Index (14 RSI): | 38.16 | Sell |
| Chaikin Money Flow: | 2857375 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (50.57 - 61.31) | Sell |
| Bollinger Bands (100): | (46.52 - 79.44) | Sell |
LMND Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.05 | Buy |
| 20-day SMA: | 16 | Buy |
| 50-day SMA: | 16.71 | Sell |
| 200-day SMA: | 15.9 | Buy |
| 8-day EMA: | 16.14 | Buy |
| 20-day EMA: | 16.15 | Buy |
| 50-day EMA: | 16.46 | Buy |
| 200-day EMA: | 16.58 | Sell |
VKTX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 50.48 | Buy |
| 20-day SMA: | 54.1 | Sell |
| 50-day SMA: | 63.93 | Sell |
| 200-day SMA: | 39 | Buy |
| 8-day EMA: | 50.61 | Buy |
| 20-day EMA: | 54.34 | Sell |
| 50-day EMA: | 59.63 | Sell |
| 200-day EMA: | 45.62 | Buy |
Lemonade Earnings Growth & LMND Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.01 per share, an increase this year of $1.03 per share, and an increase next year of $0.27 per share.
Viking Therapeutics Earnings Growth & VKTX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.06 per share, an increase next quarter of $0.00 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.43 per share.
Lemonade Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Viking Therapeutics Technical Analysis
| Jun 13 | Jun 14 | Jun 17 | Jun 18 | Jun 20 | Jun 21 | Jun 24 | Jun 25 | Jun 26 | Jun 27 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun | ||||||||||
| 13 | 14 | 17 | 18 | 20 | 21 | 24 | 25 | 26 | 27 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||